Supplementary Table 1. Percentage of CA-MSCs (CD44+CD73+CD49α+ CD90+) from primary human pancreatic cancer derived CAF cultures and accompanying clinical data. Supplementary Table 2. Extent of local invasion, lung tumor emboli, and liver metastasis in tumors that were derived from injections of tumor cells alone, tumor cells + CAF, and tumor cells + CA-MSCs (n=8 per group) at six weeks post implantation. Supplementary Table 3. Percentage of CD10 expressing CA-MSCs from primary human pancreatic cancer derived CAF cultures.